Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methotrexate for ankylosing spondylitis.

J Chen1, C Liu, J Lin

  • 1TheFirst Affiliated Hospital of Fujian Medical University, Department of Hematology and Rheumatology, Fuzhou, Fujian Province, China. drjunminchen@hotmail.com

The Cochrane Database of Systematic Reviews
|October 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of acupuncture and moxibustion for keeping shape.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·1999
Same author

Two-effective-source method for the calculation of in-air output at various source-to-detector distances in wedged fields.

Medical physics·1999
Same author

Follow up of women with simple ovarian cysts detected by transvaginal sonography in the Tokyo metropolitan area.

British journal of obstetrics and gynaecology·1999
Same author

(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase.

Journal of medicinal chemistry·1999
Same author

Expression analysis of multidrug resistance associated genes in neuroblastomas.

Oncology reports·1999
Same author

A random survey of the Cryptosporidium parvum genome.

Infection and immunity·1999
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Methotrexate (MTX) showed no significant benefits for ankylosing spondylitis (AS) in trials. More high-quality research is needed to determine MTX

Area of Science:

  • Rheumatology
  • Clinical Pharmacology

Background:

  • Ankylosing spondylitis (AS) is a chronic inflammatory condition primarily affecting the spine.
  • Current treatments focus on symptom management with NSAIDs, with DMARDs considered for refractory cases.

Purpose of the Study:

  • To assess the efficacy and safety of methotrexate (MTX) in treating ankylosing spondylitis.

Main Methods:

  • Systematic review of randomized and quasi-randomized controlled trials.
  • Searches conducted across multiple databases (CENTRAL, MEDLINE, EMBASE, CINAHL) up to November 2005.
  • Data extraction and quality assessment performed by independent reviewers.

Main Results:

  • Three trials with 116 patients were analyzed.

Related Experiment Videos

  • No statistically significant differences in primary outcomes (physical function, pain, spinal mobility) were observed between MTX and control groups.
  • A composite response rate showed a statistically significant benefit for MTX, but individual outcome measures did not, questioning its clinical relevance. No serious adverse events were reported.

    • Conclusions:

    • Insufficient evidence supports the use of MTX for ankylosing spondylitis.
    • High-quality, larger, and longer-duration randomized controlled trials are necessary to definitively establish MTX's efficacy and role in AS management.